Señales en vivo de ATXS | Maximiza tus Ganancias con Getagraph.com

COMPRAR 122912 min ago

@ $14.28

Emitido: 14 feb 2024 @ 12:06

Retorno: -28.78%

Señal anterior: feb 13 - 14:46

Señal anterior: Vender

Retorno: -0.35 %

Live Chart Being Loaded With Signals

Commentary (9 may 2024 @ 16:00):

Stats
Volumen de hoy	654 090
Volumen promedio	1.03M
Capitalización de mercado	558.47M
EPS	$0 ( 2024-03-27 )
Próxima fecha de ganancias	( $-0.360 ) 2024-06-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.20
ATR14	$0.0180 (0.18%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Agarwal Sunil	Buy	28 200	Stock Option (Right to Buy)
2024-04-05	Agarwal Sunil	Buy	0
2024-04-01	Morabito Christopher	Sell	10 000	Stock Option (Right to Buy)
2024-04-01	Morabito Christopher	Buy	10 000	Common Stock
2024-04-01	Morabito Christopher	Sell	10 000	Common Stock

INSIDER POWER
96.96
Last 97 transactions
Buy: 15 860 733 \| Sell: 474 752

Volumen Correlación

Largo: -0.09 (neutral)

Corto: 0.35 (neutral)

Signal:(45.11) Neutral

Astria Therapeutics, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Astria Therapeutics, Inc. Correlación - Moneda/Commodity

-0.61
( weak negative )

-0.33
( neutral )

0.00
( neutral )

-0.59
( weak negative )

-0.17
( neutral )

-0.42
( neutral )

Astria Therapeutics, Inc. Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-2.42

FY	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-2.42

FY	2022
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$-3.43

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-49.16

Financial Reports:

No articles found.

Astria Therapeutics, Inc.

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.